» Articles » PMID: 30100610

Genomic Sequencing in Acutely Ill Infants: What Will It Take to Demonstrate Clinical Value?

Overview
Journal Genet Med
Publisher Elsevier
Specialty Genetics
Date 2018 Aug 14
PMID 30100610
Citations 9
Authors
Affiliations
Soon will be listed here.
Citing Articles

3-hour genome sequencing and targeted analysis to rapidly assess genetic risk.

Zalusky M, Gustafson J, Bohaczuk S, Mallory B, Reed P, Wenger T Genet Med Open. 2024; 2.

PMID: 39421454 PMC: 11484281. DOI: 10.1016/j.gimo.2024.101833.


Positioning whole exome sequencing in the diagnostic pathway for rare disease to optimise utility: a protocol for an observational cohort study and an economic evaluation.

Hayeems R, Bernier F, Boycott K, Hartley T, Michaels-Igbokwe C, Marshall D BMJ Open. 2022; 12(10):e061468.

PMID: 36216418 PMC: 9557316. DOI: 10.1136/bmjopen-2022-061468.


Perspectives of United States neonatologists on genetic testing practices.

Wojcik M, Del Rosario M, Agrawal P Genet Med. 2022; 24(6):1372-1377.

PMID: 35304021 PMC: 9272826. DOI: 10.1016/j.gim.2022.02.009.


Cost Efficacy of Rapid Whole Genome Sequencing in the Pediatric Intensive Care Unit.

Kobayashi E, Waldman B, Engorn B, Perofsky K, Allred E, Briggs B Front Pediatr. 2022; 9:809536.

PMID: 35141181 PMC: 8818891. DOI: 10.3389/fped.2021.809536.


The IDeaS initiative: pilot study to assess the impact of rare diseases on patients and healthcare systems.

Tisdale A, Cutillo C, Nathan R, Russo P, Laraway B, Haendel M Orphanet J Rare Dis. 2021; 16(1):429.

PMID: 34674728 PMC: 8532301. DOI: 10.1186/s13023-021-02061-3.